Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIBIV) research hub

A Phase II, Non-comparative, Open label, Multi-centre, International Study of MEDI4736, in Patients with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (Stage IIIB-IV) who have received at least Two Prior Systemic Treatment Regimens Including One Platinum-based Chemotherapy Regimen (ATLANTIC)

This study is looking at a new medicine called IMFINZI for people in the UK with advanced lung cancer who have already had at least two different treatments. It wants to see how well the medicine shrinks tumours and helps people live longer, while also checking for any side effects.